There is no reliable national ranking of Norwegian medical specialties by shortage, and the reason is worth knowing before you go looking for one. The headline figure — NAV’s estimate of 550 legespesialister in its 2026 employer survey — sits on an occupational classification that Helsedirektoratet says cannot properly separate general practitioners from other specialists, or place doctors in training at all. Where the shortages actually bite is better read from what employers are willing to pay to fill posts.
Sources: The NAV figure is read from table V2 of the survey’s own workbook; the classification caveat is Helsedirektoratet’s. Both are revised periodically.
Sources: NAV — Bedriftsundersøkelsen 2026, figurer og tabeller (table V2); Helsedirektoratet — estimert mangel på helsepersonell; Meld. St. 11 (2025–2026) Helsepersonellplan 2040; Spesialistforskriften, FOR-2016-12-08-1482.
Why the headline number cannot be broken down
NAV’s table gives legespesialister an estimated shortage of 550, with a 95 per cent confidence interval of 450 to 700. That is the figure everyone quotes. Here is why it does not mean what people take it to mean.
NAV classifies occupations using STYRK-08, built on the international ISCO standard. For doctors it offers two categories: allmennpraktiserende leger and legespesialister.
That works badly in Norway, and Helsedirektoratet sets out why in three steps.
The categories are not mutually exclusive here. Many Norwegian GPs are specialists — in general medicine — so a doctor can plausibly be reported under either heading.
Some employers have probably reported them as specialists. The directorate’s assessment is that specialists in general medicine have likely been recorded as “legespesialister” by some businesses, inflating that category with doctors whose shortage belongs to general practice.
Doctors in specialisation fit neither. A LIS doctor training in anything other than general medicine does not belong naturally in either category.
Helsedirektoratet’s conclusion is blunt: these difficulties make the results for doctors hard to interpret, and should be taken into account when the classification is next revised.
So the 550 figure is real as a survey output, but it is not a count of hospital consultants, and it cannot be disaggregated by specialty. If a page tells you Norway is short of exactly 550 hospital specialists, it is reading more into the number than the number carries.
What the long-range projection does and does not cover
SSB’s Helsemod projections, used in Meld. St. 11, cover 14 authorised personnel groups and include leger as one of them. That gives a projection for doctors as a whole.
It does not model individual specialties. Nothing in the published table tells you whether Norway will be short of pathologists rather than paediatricians in 2040. The projection rests on the reference path’s assumptions and uses 2024 as the base year for service use and resource input, assumed to carry forward — so a projected doctor shortage partly reflects an assumption that doctors keep doing the work doctors did in 2024.
The much larger projected gaps sit elsewhere entirely: sykepleiere and helsefagarbeidere account for roughly 40,600 of the 42,400 full-time equivalents projected to be missing by 2040. The melding also notes that the modelled figure understates total staffing pressure, because the services depend on groups the model does not cover.
The evidence that is actually specialty-specific
Where national statistics fail, recruitment behaviour fills in. Employers do not offer money to fill posts that are easy to fill, and Norwegian health trusts publish those incentives openly in job advertisements.
Psychiatry is the clearest current signal. Northern health trusts have advertised recruitment supplements — one northern hospital offering 75,000 kroner to a doctor appointed permanently who takes specialisation in psychiatry — alongside the general 25,000 kroner a year of student-loan write-off available to those registered as resident in qualifying municipalities.
Two things follow. Incentives of that kind indicate genuine difficulty filling posts. And they are geographic as much as they are clinical — the same specialty may be straightforward to recruit for in Oslo and hard in Vesterålen.
A second signal is structural. The role of avtalespesialister — specialists in private practice under an operating-grant agreement with a regional health authority — is substantial: their activity has accounted for roughly a fifth to a quarter of publicly funded outpatient activity in somatic fields and in adult mental health care. Professional bodies have argued that specialist capacity is already constrained and will tighten further, which is one reason those agreements matter.
How to research a specific specialty
If you have a specialty in mind, the honest method is not to look for a national league table but to look at four things.
Advertised posts and their terms. Recruitment supplements, permanent versus temporary contracts, and how long posts stay advertised.
Which health trusts are advertising. Persistent advertising from the same northern or rural trusts is a stronger signal than a single vacancy in a central hospital.
Whether the specialty has an avtalespesialist route. That affects both capacity and how you might eventually practise.
Whether the training pathway is open where you want to live. Specialist training is delivered through the regional health authorities and their trusts, so availability is geographic too.
The sequence that comes first
None of this changes the route in, and for doctors trained abroad the route is long.
Norwegian authorisation comes first — and which system reads your file depends on where you trained rather than your nationality, a distinction worth settling before anything else. The hub article covers the process from outside the EEA.
Then LIS1, which is the genuine bottleneck and is competitive. The LIS1 article covers what it is and how posts are allocated — including the change from January 2026 allowing certain formalised post-graduate programmes completed abroad to be assessed as counting towards it.
Specialist recognition is then a separate application again, with its own fee.
So a shortage in a given specialty is useful information about where you might eventually work. It is not a shortcut, and no health trust can substitute its need for the steps above.
For doctors trained outside the EEA, a Norwegian test at CEFR B2 is a legal condition of authorisation before any of it. What the CEFR levels describe is the requirement no specialty shortage removes.